[1] Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model [J]. Am J Respir Crit Care Med, 2006, 173(7):769-776.[2] Wynn TA. Integrating mechanisms of pulmonary fibrosis [J]. J Exp Med, 2011, 208(7):1339-1350.[3] Iyama T, Wilson DM 3rd. DNA repair mechanisms in dividing and non-dividing cells [J]. DNA Repair (Amst), 2013, 12(8):620-636.[4] Ba X, Garg NJ. Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases [J]. Am J Pathol, 2011, 178(3):946-955.[5] Liu L, Ke Y, Jiang X, et al. Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-kappaB transcription in murine macrophages [J]. Hum Immunol, 2012, 73(5):439-447.[6] Li HY, Pan L, Ke YS, et al. Daidzein suppresses pro-inflammatory chemokine Cxcl2 transcription in TNF-alpha-stimulated murine lung epithelial cells via depressing PARP-1 activity [J]. Acta Pharmacol Sin, 2014, 35(4):496-503.[7] Ba X, Gupta S, Davidson M, et al. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes [J]. J Biol Chem, 2010, 285(15):11596-11606.[8] Kage H, Borok Z. EMT and interstitial lung disease:a mysterious relationship [J]. Curr Opin Pulm Med, 2012, 18(5):517-523.[9] Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis [J]. Exp Lung Res, 2015, 41(2):57-73.[10] 辛维娜, 蒋荣娜, 石卓, 等.甘草酸二铵对博莱霉素致肺纤维化大鼠血清iNOS及NO水平的影响及其抗肺纤维化的作用机制[J].吉林大学学报:医学版, 2013, 39(1):38-41.[11] Zhao H, Qin HY, Cao LF, et al. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis[J]. Toxicol Lett, 2014, 232(1):213-220.[12] Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis [J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(2):L152-160.[13] Virag L. Poly(ADP-ribosyl)ation in asthma and other lung diseases [J]. Pharmacol Res, 2005, 52(1):83-92.[14] Di Paola R, Talero E, Galuppo M, et al. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis [J]. Respir Res, 2011, 12(1):41-52.[15] Wang Z, Wang F, Tang T, et al. The role of PARP1 in the DNA damage response and its application in tumor therapy [J]. Front Med, 2012, 6(2):156-164.[16] Sonnenblick A, de Azambuja E, Azim HA Jr, et al. An update on PARPinhibitors-moving to the adjuvant setting [J]. Nat Rev Clin Oncol, 2015, 12(1):27-41.[17] 魏路清, 彭守春.间质性肺疾病的生物学标志物研究进展[J]. 中国实用内科杂志, 2014, 34(8):748-751.[18] 胡红, 刘又宁.糖皮质激素在呼吸疾病治疗中的应用[J].中国实用内科杂志, 2013, 33(10):764-767. |